U.S. Intrauterine Devices Market - By Product (Copper IUD, Hormonal IUD), Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), End-use (Hospitals, Gynecology Clinics, Community Health Care Centers) & Forecast, 2024 – 2032

U.S. Intrauterine Devices Market Size

U.S. Intrauterine Devices Market size was valued at around USD 1.4 billion in 2023 and is expected grow at a CAGR of 9.5% from 2024 to 2032. Rising awareness among women, supportive regulation and initiatives by government are among the key factors fueling the market growth. Government initiatives in the U.S. aimed at preventing unwanted pregnancies and abortions have significantly driven the growth of the market.
 

These initiatives focus on increasing access to contraception, providing comprehensive sex education, and supporting family planning services. Federal and state initiatives promoting comprehensive sex education that includes information about various contraceptive methods have led to increased awareness and acceptance of IUDs. As one of the largest providers of reproductive health services in the U.S., Planned Parenthood plays an important role in offering and promoting the adoption of IUDs. Government funding and support for such organizations enhance their capacity to provide these services.
 

For instance, according to a report by the Guttmacher Institute in 2021, the ACA’s contraceptive coverage mandate has significantly increased the use of long-acting reversible contraception (LARC), including IUDs. The significant increase in the use of LARCs underscores the effectiveness of these initiatives in promoting the adoption of IUDs.
 

Intrauterine devices (IUDs) are small, T-shaped contraceptive devices inserted into the uterus to prevent pregnancy. These devices are made of flexible plastic and are designed to be a long-term, reversible form of birth control.
 

U.S. Intrauterine Devices Market Trends

The U.S. IUDs industry has seen several technological advancements and ongoing studies that are enhancing the safety, effectiveness, and user experience of IUDs.
 

• Research and development efforts are focused on increasing the duration of effectiveness of hormonal IUDs. The latest IUDs can now offer protection for up to 7 years, compared to the previous standard of 3-5 years.
   
• Additionally, some of the latest hormonal IUDs allow for adjustable hormone release levels, catering to individual needs and minimizing side effects. This customization helps in managing conditions such as heavy menstrual bleeding more effectively.
   
• Moreover, research is ongoing to develop IUDs using alternative hormones to levonorgestrel, providing more options for women who may have sensitivities or adverse reactions to certain hormones.  In recent years, the FDA has approved several new IUDs that incorporate these technological advancements. For example, in 2020, the FDA approved a lower-dose levonorgestrel-releasing IUD that provides effective contraception for up to 5 years.
   
• Numerous clinical trials are ongoing in the U.S. to test the efficacy and safety of next-generation IUDs. These trials are crucial in bringing innovative products to market and gaining user trust.
   

U.S. Intrauterine Devices Market Analysis

Based on product, the market is categorized into copper IUD and hormonal IUD. The hormonal IUD segment dominated the market with a revenue of around USD 1.1 billion in 2023.
 

• Hormonal IUDs are also used for non-contraceptive health benefits, such as treating chronic pelvic pain, managing symptoms of polycystic ovary syndrome (PCOS), and providing hormone replacement therapy in perimenopausal women.
   
• Moreover, surveys and studies indicate higher satisfaction rates among women using hormonal IUDs due to their additional health benefits and fewer side effects related to menstruation, contributing to its rising preference.
   

Based on age group, the U.S. intrauterine devices market is categorized into 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, and 45+. The 30-34 age group segment anticipated to dominate the market with a revenue of around USD 772.6 million in 2032.
 

• Women in the 30-34 age group are often in their peak reproductive years and are actively engaged in family planning. This age group commonly seeks reliable, long-term contraception to either space out pregnancies or to delay childbearing until later in their 30s or beyond.
   
• Moreover, compared to younger or older women, those in the 30-34 age group generally have fewer health contraindications for IUD use, making them ideal candidates for this form of contraception.
   

Based on end-use, the U.S. intrauterine devices market is categorized into hospitals, gynecology clinics, and community health care centers. The hospital segment dominated the market with a revenue share of around 49% 2023.
 

• Hospitals provide integrated care, where patients can receive consultations, diagnostic tests, and IUD insertion procedures all in one place. This convenience attracts more patients to hospital settings for their contraceptive needs.
   
• Additionally, hospitals generally serve a larger patient base compared to smaller clinics or community health centers. The high patient volume translates to a greater number of IUD insertions performed in hospitals.
   

South Atlantic intrauterine devices market accounted for USD 275.5 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The South Atlantic region has several densely populated and rapidly urbanizing areas, such as Miami, Atlanta, and Charlotte. Higher population density increases the demand for contraceptive options, including IUDs.
  
   
• Additionally, local health departments and non-profit organizations actively promote awareness about family planning and contraceptive options. Educational campaigns about the benefits and safety of IUDs contribute to increased product adoption.
   

U.S. Intrauterine Devices Market Share

The U.S. intrauterine devices industry is consolidated in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel IUD devices with improved efficiency and cost-effectiveness are key market strategies for device manufacturers, driving competition and innovation in the industry.
 

U.S. Intrauterine Devices Market Companies

Some of the eminent market participants operating in the U.S. intrauterine devices industry include:

• Allergan (AbbVie Inc.)
• Bayer AG
• CooperSurgical Inc.
• Durbin
• Meril Life Sciences Pvt. Ltd.
• Mylan N.V. (Viatris)
• Pregna International Ltd.
• SMB Corporation of India
   

U.S. Intrauterine Devices Industry News:

• In November 2023, Bayer and CrossBay Medical Inc., announced the collaboration and option to license agreement that allow the development and production of a single-handed inserter to be combined with Bayer’s leading hormonal IUS portfolio. This strategy enhanced the company’s product portfolio and its competitiveness in the market.
   
• In December 2022, CooperSurgical, Inc., announced their partnership to launch a new consumer engagement solution for CooperSurgical's hormone-free IUD, Paragard, an FDA-approved intrauterine device that prevents pregnancy for up to 10 years. This launch enabled the company to have an increased customer base.
   

U.S. intrauterine devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product   

• Copper IUD
• Hormonal IUD

Market, By Age Group  

• 15-19
• 20-24
• 25-29
• 30-34
• 35-39
• 40-44
• 45+

Market, By End-use

• Hospitals
• Gynecology clinics
• Community health care centers

The above information is provided for the following zones:

• East North Central
  • Illinois
  • Indiana
  • Michigan
  • Ohio
  • Wisconsin
• West South Central
  • Arkansas
  • Louisiana
  • Oklahoma
  • Texas
• South Atlantic
  • Delaware
  • Florida
  • Georgia
  • Maryland
  • North Carolina
  • South Carolina
  • Virginia
  • West Virginia
  • Washington, D.C.
• Northeast
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania
• East South Central
  • Alabama
  • Kentucky
  • Mississippi
  • Tennessee
• West North Central
  • Iowa
  • Kansas
  • Minnesota
  • Missouri
  • Nebraska
  • North Dakota
  • South Dakota
• Pacific Central
  • Alaska
  • California
  • Hawaii
  • Oregon
  • Washington
• Mountain States
  • Arizona
  • Colorado
  • Utah
  • Nevada
  • New Mexico
  • Idaho
  • Montana
  • Wyoming